Status:
UNKNOWN
Effect of Dexamethasone on Migraine Headache
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Migraine Headache
Eligibility:
All Genders
15-40 years
Phase:
PHASE1
Brief Summary
Dexamethasone is a safe and cheap abortive therapy for migraine headache. The effect of it is never evaluate and not correlate with the effect of popular anti migraine medication such as dihydroergota...
Eligibility Criteria
Inclusion
- Migraine attack according to international headache society criteria
- Migraine without aura; at least 5 attack with mean duration of 4 to 72 hours and 2 of following:
- Unilateral
- Pulsatile
- Severe enough to impair daily activity
- Aggravate with walking and climbing, also 1 of following:
- Nausea and or vomiting
- Photophobia and phonophobia, and not contributed to other headache.
- Migraine with aura; at least 2 attacks with 3 of following:
- One reversible aura
- Aura became apparent at least in 4 minutes
- Aura not lasting more than 60 minutes
- Headache develops in less than 60 minutes after aura
Exclusion
- Hypertension
- Ischemic heart disease
- Basilar migraine with sign and symptoms such as:
- Diplopia
- Ataxia
- Dysarthria
- Dysphagia
- Weakness
- Sensory disorder
- Drowsiness
- Peripheral vascular disease
- Sepsis
- Age more than 40 and less than 15 year old
- Pregnancy
- Use of triptans and ergots derivatives in past 24 hours
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00733382
Start Date
February 1 2008
End Date
August 1 2009
Last Update
August 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peyman Petramfar
Shiraz, Fars, Iran